{"transactions":[{"id":705155,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:24:44.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001221","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033426001221/form4.xml","form_type":"4"}},{"id":731915,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:16:39.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000055","document":"wk-form4_1781813796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000055/wk-form4_1781813796.xml","form_type":"4"}},{"id":924750,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:45:34.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000195","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033426000195/form4.xml","form_type":"4"}},{"id":1011256,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"price":19793,"reported_value":19793,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2026-04-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011255,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":12566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"balance_after":12566,"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":12566},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011254,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":6846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"balance_after":6846,"derivative":{"exercise_price":6.24,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":6846},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011253,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":false,"price":25000,"reported_value":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1039270,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:15:37.000Z","date":"2025-09-12","kind":"purchase","planned":false,"acquired":true,"shares":3175,"price":7.7852,"value":24718.01,"ownership":{"direct":true},"balance_after":3894,"source":{"system":"sec-edgar","filing":"0001288232-25-000009","document":"wk-form4_1758053735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000128823225000009/wk-form4_1758053735.xml","form_type":"4"}},{"id":1129160,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:39:23.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019047","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019047/rdgdoc.xml","form_type":"4"}},{"id":1158956,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-05-05T21:24:07.000Z","date":"2025-05-01","kind":"purchase","planned":false,"acquired":true,"price":25000,"reported_value":25000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-000789","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425000789/form4.xml","form_type":"4"}},{"id":1322745,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:00:49.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424001925/form4.xml","form_type":"4"}},{"id":1515869,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T01:20:26.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":49200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":49200,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":49200},"source":{"system":"sec-edgar","filing":"0001437749-24-017182","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924017182/rdgdoc.xml","form_type":"4"}},{"id":1606710,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606709,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606708,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606707,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606706,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":2000,"derivative":{"exercise_price":1.55,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606705,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606704,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606703,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606702,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606701,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on March 5, 2021 and was previously reported as covering 30,000 shares at an exercise price of $1.52 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, one third (1/3rd) of the shares subject to the option shall vest on the two (2) year anniversary of the Vesting Commencement Date, one third (1/3rd) of the shares subject to the option shall vest on the three (3) year anniversary of the Vesting Commencement Date, such that the option shall be fully vested on the three (3) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 5, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on March 5, 2021 and was previously reported as covering 30,000 shares at an exercise price of $1.52 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1790826,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2023-09-01T22:00:38.000Z","date":"2023-08-30","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on September 30, 2023."}],"balance_after":8500,"derivative":{"exercise_price":4.655,"expiration_date":"2033-08-30","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001493152-23-031535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000149315223031535/ownership.xml","form_type":"4"}},{"id":1812830,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-08T20:54:07.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":1083,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-23-001482","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033423001482/form4.xml","form_type":"4"}},{"id":1839500,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T18:05:34.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":667,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-23-001201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033423001201/form4.xml","form_type":"4"}},{"id":1869541,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:33:35.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 31, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":5.04,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-23-016494","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923016494/rdgdoc.xml","form_type":"4"}},{"id":1900840,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-09T01:51:40.000Z","date":"2023-04-25","kind":"grant","planned":false,"acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, April 25, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's eighth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":39200,"derivative":{"exercise_price":5.59,"expiration_date":"2033-04-24","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001437749-23-013124","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923013124/rdgdoc.xml","form_type":"4"}},{"id":1942906,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-21T20:32:40.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":519,"price":4.8215,"value":2502.3585,"ownership":{"direct":true},"balance_after":719,"source":{"system":"sec-edgar","filing":"0001437749-23-007397","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923007397/rdgdoc.xml","form_type":"4"}},{"id":2214643,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2022-07-05T20:05:43.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on August 1, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.255,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-018529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000149315222018529/ownership.xml","form_type":"4"}},{"id":2218636,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T21:19:03.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.52,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-22-016300","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922016300/rdgdoc.xml","form_type":"4"}},{"id":2221048,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T21:17:53.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 24, 2022."}],"balance_after":10000,"derivative":{"exercise_price":0.326,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001640334-22-001357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033422001357/form4.xml","form_type":"4"}},{"id":2258063,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-25T00:58:01.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":200,"price":4.87,"value":974.0,"ownership":{"direct":true},"balance_after":200,"source":{"system":"sec-edgar","filing":"0001437749-22-013468","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922013468/rdgdoc.xml","form_type":"4"}},{"id":2561968,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-09-23T00:37:57.000Z","date":"2021-09-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 22, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.24,"expiration_date":"2031-09-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000905718-21-001223","document":"kintara_fm4sep222021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821001223/kintara_fm4sep222021.xml","form_type":"4"}},{"id":2624790,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-26T20:22:09.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 16, 2021."}],"balance_after":10000,"derivative":{"exercise_price":1,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001640334-21-001675","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033421001675/form4.xml","form_type":"4"}},{"id":2732981,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Grant)","published_at":"2021-05-03T20:34:19.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, one-third of the options vest on April 29, 2022, with the remaining options vesting in eight equal quarterly installments commencing on July 29, 2022."}],"balance_after":75000,"derivative":{"exercise_price":1.37,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000905718-21-000652","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000652/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2799619,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-09T21:24:25.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, one third (1/3rd) of the shares subject to the option shall vest on the two (2) year anniversary of the Vesting Commencement Date, one third (1/3rd) of the shares subject to the option shall vest on the three (3) year anniversary of the Vesting Commencement Date, such that the option shall be fully vested on the three (3) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 5, 2021."}],"balance_after":30000,"derivative":{"exercise_price":1.52,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001640334-21-000542","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033421000542/form4.xml","form_type":"4"}},{"id":4569274,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Restricted Stock Units","published_at":"2016-11-03T00:39:07.000Z","date":"2016-10-31","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 28, 2016, the reporting person was granted 100,000 restricted stock units. In connection with the execution of the Merger Agreement, the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 28, 2016, the reporting person was granted 100,000 restricted stock units. In connection with the execution of the Merger Agreement, the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-16-148045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000120919116148045/doc4.xml","form_type":"4"}},{"id":4569273,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Restricted Stock Units","published_at":"2016-11-03T00:39:07.000Z","date":"2016-10-31","kind":"exercise","acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 4, 2014, the reporting person was granted 92,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the \"Issuer\"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the \"Merger Agreement\"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of the remaining 46,000 restricted stock units in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 4, 2014, the reporting person was granted 92,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the \"Issuer\"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the \"Merger Agreement\"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of the remaining 46,000 restricted stock units in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001209191-16-148045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000120919116148045/doc4.xml","form_type":"4"}},{"id":4569272,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Common Stock","published_at":"2016-11-03T00:39:07.000Z","date":"2016-10-31","kind":"tax_withholding","acquired":false,"shares":45580,"price":0.36,"value":16408.8,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax withholding obligations."}],"balance_after":106447,"source":{"system":"sec-edgar","filing":"0001209191-16-148045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000120919116148045/doc4.xml","form_type":"4"}},{"id":4569271,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Common Stock","published_at":"2016-11-03T00:39:07.000Z","date":"2016-10-31","kind":"exercise","acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis."}],"balance_after":152027,"source":{"system":"sec-edgar","filing":"0001209191-16-148045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000120919116148045/doc4.xml","form_type":"4"}},{"id":4569270,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Common Stock","published_at":"2016-11-03T00:39:07.000Z","date":"2016-10-31","kind":"tax_withholding","acquired":false,"shares":20967,"price":0.36,"value":7548.12,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax withholding obligations."}],"balance_after":52027,"source":{"system":"sec-edgar","filing":"0001209191-16-148045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000120919116148045/doc4.xml","form_type":"4"}},{"id":4569269,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"SEYMOUR TAMARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Common Stock","published_at":"2016-11-03T00:39:07.000Z","date":"2016-10-31","kind":"exercise","acquired":true,"shares":46000,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis."}],"balance_after":72994,"source":{"system":"sec-edgar","filing":"0001209191-16-148045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000120919116148045/doc4.xml","form_type":"4"}}]}